The recall only involves Sucralfate Tablets 1g manufactured after June 2023. Nostrum Labs is recalling all lots within expiry of Sucralfate Tablets 1g as the Company has shut down operations at its US ...
CLEVELAND, Ohio – Nostrum Laboratories Inc. has recalled its Sucralfate Tablets USP 1 gram because the company filed Chapter 11 bankruptcy, shut down operations and terminated its operational ...
Nostrum Laboratories is recalling one of its medications, following the company’s closure due to bankruptcy. Nostrum is recalling its Sucralfate Tablets USP 1 gram, which were manufactured after June ...
Nostrum Laboratories, Inc. (“Nostrum Labs”) filed Chapter 11 bankruptcy on September 30, 2024. In connection with that filing, the company has ceased and shutdown operations and terminated its ...
This recall pertains only to Sucralfate Tablets USP 1 gram, all lots with expiry, manufactured by Nostrum Labs after June 2023. No other Nostrum Labs products are affected by this recall. Nostrum Labs ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results